SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-554394
Filing Date
2016-04-25
Accepted
2016-04-25 17:23:39
Documents
14
Period of Report
2016-06-09
Effectiveness Date
2016-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d165946ddef14a.htm DEF 14A 755662
2 GRAPHIC g165946g81p13.jpg GRAPHIC 36046
3 GRAPHIC g165946pcpg001a.jpg GRAPHIC 12405
4 GRAPHIC g165946pcpg001bn.jpg GRAPHIC 1748
5 GRAPHIC g165946pcpg001c.jpg GRAPHIC 1674
6 GRAPHIC g165946pcpg001d.jpg GRAPHIC 23773
7 GRAPHIC g165946pcpg001e.jpg GRAPHIC 1247
8 GRAPHIC g165946pcpg001f.jpg GRAPHIC 626
9 GRAPHIC g165946pcpg001g.jpg GRAPHIC 5843
10 GRAPHIC g165946pcpg001h.jpg GRAPHIC 765
11 GRAPHIC g165946pcpg001i.jpg GRAPHIC 5904
12 GRAPHIC g165946pcpg002a.jpg GRAPHIC 2986
13 GRAPHIC g165946pcpg002b.jpg GRAPHIC 924
14 GRAPHIC g165946pcpg002c.jpg GRAPHIC 783
  Complete submission text file 0001193125-16-554394.txt   882349
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51173 | Film No.: 161589881
SIC: 2834 Pharmaceutical Preparations